Meeting program

All times are displayed in GMT+3

09:00 - 09:15 GMT+3 Opening Ceremony

09:15 - 10:15 GMT+3 Session 1: Lymphomas

Chairs: A Barefah (Saudi Arabia)

  • Updates on Hodgkin Lymphoma
    AJM Ferreri (Italy)
  • Updates on CART-Cells & bispecific antibodies in NHL
    C Chabannon (France)

10:15 - 11:15 GMT+3 Session 2: Chronic Lymphoproliferative Disorders

Chair: O Radhwi (Saudi Arabia)

  • Updates on CLL
    R Foà (Italy)
  • Infection and inflammation as drivers of MZLs
    M Ponzoni (Italy)

11:15 - 12:00 GMT+3 Special session: Myeloid malignancies

Chair: A Radhi (Bahrain) & S Unal (Türkiye)

  • From clonal hematopoiesis to myeloid malignancy - Options for leukemia prevention?
    K Gronbaek (Denmark)
  • Inherited bone marrow failure and diamond blackfan anemia
    J De La Fuente (United Kingdom)

11:15 - 13:15 GMT+3 Prayer & Lunch

13:15 - 14:15 GMT+3 Session 3: Acute Leukemia Adults

Chair: S Bahashwan (Saudi Arabia) & L Kaynar (Türkiye)

  • Novel insights into AML treatment
    K Döhner (Germany)
  • Risk stratification for the treatment of ALL
    J Trka (Czechia)

14:15 - 15:15 GMT+3 Session 4: Myeloma

Chair: H Alahwal (Saudi Arabia)

  • Updates for front line therapy for newly diagnosed MM
    R Mina (Italy)
  • Treatment of MM patients based on their frailty status
    A Larocca (Italy)
  • Updates in using novel therapies and immunotherapies for multiple myeloma
    D Coriu (Romania)

15:15 - 15:30 GMT+3 Coffee break

15:30 - 16:30 GMT+3 Regional Joint Symposium Sickle Cell Anemia & Thalassemia

Chair: M Qari (Saudi Arabia)

  • Patient blood management
    S Hindawi (Saudi Arabia)
  • Current and new concept in the management of thalassemia
    A El-Beshlawy (Egypt)
  • Locally Manufactured Deferasirox versus Desferrioxamine in Thalassemia Major Patients
    H Hadi Almusawi (Iraq)

16:30 - 17:30 GMT+3 Session 5: Thrombosis & Hemostasis

Chair: S Al Jaouni (Saudi Arabia)

  • Decisions in clinical management
    S Stanworth (United Kingdom)
  • Biomarkers and risk prediction of cancer associated thrombosis 
    Z Bagoly (Hungary)

17:30 - 17:45 GMT+3 Closing ceremony